|
"hsu w h"的相關文件
顯示項目 156-165 / 304 (共31頁)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2020-01-06T03:09:05Z |
Cellulosic conversion in ionic liquids (ILs): Effects of H 2 O/cellulose molar ratios, temperatures, times, and different ILs on the production of monosaccharides and 5-hydroxymethylfurfural (HMF)
|
Hsu, W.-H.; Lee, Y.-Y.; Peng, W.-H.; Wu, K.C.-W.; KEVIN CHIA-WEN WU |
| 臺大學術典藏 |
2020-01-06T03:09:05Z |
Synthesis of metal ion-histidine complex functionalized mesoporous silica nanocatalysts for enhanced light-free tooth bleaching
|
Lee, B.-S.; Huang, L.-C.; Hong, C.-Y.; Wang, S.-G.; Hsu, W.-H.; Yamauchi, Y.; Hsieh, C.-J.; Lai, J.-Y.; Wu, K.C.-W.; KEVIN CHIA-WEN WU |
| 臺大學術典藏 |
2020-01-06T03:03:54Z |
Detection of K+ Efflux from Stimulated Cortical Neurons by an Aptamer-Modified Silicon Nanowire Field-Effect Transistor
|
Anand, A.; Liu, C.-R.; Chou, A.-C.; Hsu, W.-H.; Ulaganathan, R.K.; Lin, Y.-C.; Dai, C.-A.; Tseng, F.-G.; Pan, C.-Y.; Chen, Y.-T.; CHI-AN DAI |
| 國立臺灣科技大學 |
2020 |
In vitro siRNA delivery via diethylenetriamine- and tetraethylenepentamine-modified carboxyl group-terminated Poly(amido)amine generation 4.5 dendrimers
|
Hanurry, E.Y.;Hsu, W.-H.;Darge, H.F.;Birhan, Y.S.;Mekonnen, T.W.;Andrgie, Andrgie A.T.;Chou, H.-Y.;Cheng, Cheng C.-C.;Lai, J.-Y.;Tsai, H.-C. |
| 國立臺灣科技大學 |
2020 |
Biodegradable polymer-nanoclay composites as intestinal sleeve implants installed in digestive tract for obesity and type 2 diabetes treatment
|
Hsu, W.-H.;Chang, H.-M.;Lee, Y.-L.;Prasannan, A.;Hu, C.-C.;Wang, J.-S.;Lai, J.-Y.;Yang, J.M.;Jebaranjitham, N.;Tsai, H.-C. |
| 國立臺灣科技大學 |
2020 |
Highly UV Resistant Inch-Scale Hybrid Perovskite Quantum Dot Papers
|
Li, T.-Y.;Xu, Xu X.;Lin, C.-H.;Guan, X.;Hsu, W.-H.;Tsai, M.-L.;Fang, X.;Wu, T.;He, J.-H. |
| 國立臺灣科技大學 |
2020 |
Biotin-decorated PAMAM g4.5 dendrimer nanoparticles to enhance the delivery, anti-proliferative, and apoptotic effects of chemotherapeutic drug in cancer cells
|
Hanurry, E.Y.;Mekonnen, T.W.;Andrgie, Andrgie A.T.;Darge, H.F.;Birhan, Y.S.;Hsu, W.-H.;Chou, H.-Y.;Cheng, Cheng C.-C.;Lai, J.-Y.;Tsai, H.-C. |
| 臺大學術典藏 |
2020 |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; WEI-YU LIAO; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020 |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yu C.-J.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tzu-Hsiu Tsai;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; TZU-HSIU TSAI; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H. |
| 臺大學術典藏 |
2020 |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Su K.-Y.; Chang Y.-L.; Liu Y.-N.; Hsu C.-L.; TZU-HSIU TSAI; Chen K.-Y.; Ho C.-C.; Liao W.-Y.; Yang C.-Y.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
顯示項目 156-165 / 304 (共31頁)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
每頁顯示[10|25|50]項目
|
